Synthesis and Biological Evaluation of Substituted 2-anilino-7H-pyrrolopyrimidines as PDK1 Inhibitors
Publication Date
Avondale Authors
Publisher
DOI
Original
Rights
Due to copyright restrictions this article is unavailable for download.
Crown copyright © 2014 Published by Elsevier Ltd. All rights reserved.
This article may be accessed from the publisher here.
Version
Review Status
Field of Education
Field of Research
Degree
Department
Faculty
Supervisor
Awarding Institution
Degree
Department
Faculty
Supervisor
Awarding Institution
Abstract
An efficient and scalable route for a series of novel substituted 2-anilino-7H-pyrrolopyrimidine compounds as potential inhibitors of PDK1, an important regulator of the PI3K/Akt pathway that is dysregulated in many cancers, was developed and is described. The synthetic strategy was designed around Suzuki and BuchwaldeHartwig cross-couplings of a boronate fragment and various customised anilines sequentially with 2,4-dichloro-7-tosyl-7H-pyrrolopyrimidine. All fragments were constructed separately and cross-coupled to provide access to a range of novel compounds. Biological evaluation of these was undertaken, with modest inhibition observed.
Description
Research Statement
Citation
O'Brien, N. J., Brzozowski, M., Wilson, D. J., Deady, L. W., & Abbott, B. M. (2014). Synthesis and biological evaluation of substituted 2-anilino-7H-pyrrolopyrimidines as PDK1 inhibitors. Tetrahedron, 70(33), 4947-4956. doi:10.1016/j.tet.2014.05.033